Regional Director, Medical Diagnostics – Lung Cancer

At AstraZeneca, our ambition is to push the boundaries of science to change the practice of medicine and transform the lives of patients living with cancer. To accomplish this, we focus on research and development and our commercial capabilities to deliver a new generation of medicines that have the potential to redefine cancer treatment.The Regional Director, Medical Diagnostics (RDMD), is a field-based professional responsible for liaising with external diagnostics stakeholders in their US territory who has a history of a diagnostic industry or clinical pathology experience in oncology.The RDMD is also responsible for developing and executing external engagement strategies with Key Opinion Leaders (KOLs), Key Decision Makers (KDMs), Healthcare Professionals (HCPs), and key Regional and National Pathology societies consistent with Medical Affairs teams objectives.The ideal candidate should have:

MD/DO with Board Certification in Anatomic Pathology (US Board strongly preferred)Experience working in US pathology laboratory (academic, community, or commercial)Fellowship in Molecular Pathology in addition to AP Certification is a plus.Significant experience in oncologic pathology; demonstrated expertise in lung cancer is a plus.A passion for proactively engaging internal and external leadersExperience in serving as a medical expert for their diagnostic and biomarker areaStrong commercial aptitude and/or experience in product launchAbility to translate and appropriately align commercial and scientific goals and objectivesAccountabilities

Evaluate and contribute expertise to the U.S. diagnostic strategy development for current and future AstraZeneca oncology productsCollaborate with relevant business partners for the development, alignment, and execution of the Medical Diagnostic strategy within the integrated Medical Affairs plan, launch plans, and budgetsIdentify and lead solution-based strategies to address biomarker adoption barriers, gaps, and hurdlesProvide diagnostic leadership on the design and execution of health economic and outcomes research studies and surveys in close collaboration with the Outcomes Research teamRecommend and deliver diagnostics-focused educational content targeted to HCPs, primarily to oncologists and pathologistsDevelop external engagement strategy and own relationships with key leaders in the diagnostic and biomarker area (including clinical experts and specialized pathologists)Generate pathology-related insights to shape U.S. Medical Diagnostic strategiesQualifications

MD or DO required with board certification in AP.Minimum 3 years histopathology and/or medical affairs experienceRelevant work experience in industry, clinical, or research institution with emphasis in pathology or tissue diagnosticsDeep understanding of diagnostic FDA environment, clinical laboratory practices including CAP/CLIA lab requirements and test implementationStrong knowledge of medical strategy, clinical diagnostic development, and Field Medical activitiesStrong business acumen, including an understanding of drivers behind evolving diagnostic and pathology landscapeAbility to interact productively with both commercial and scientific / medical colleaguesExperience in developing and maintaining new relationships with External ExpertsAbility to travel up to 60% of timePreferred Qualifications

Existing relationships with relevant Professional Societies and Scientific Medical ExpertsExperience in a strategy-setting role within Medical AffairsDemonstrated leadership abilities within a matrixed organizationCompleted fellowship in molecular pathologyKnowledge/expertise in lung cancer.

#J-18808-Ljbffr